• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Tekmira Pharmaceuticals Corp

+ Add to Watchlist

TKM:CN

14.2800 CAD 1.2300 7.93%

As of 15:59:59 ET on 04/17/2014.

Snapshot for Tekmira Pharmaceuticals Corp (TKM)

Open: 15.6900 Day's Range: 14.1100 - 15.7000 Volume: 318,661
Previous Close: 15.5100 52wk Range: 4.5800 - 34.6600 1-Yr Rtn: +201.90%

Stock Chart for TKM

No chart data available.
  • TKM:CN 14.3000
  • 1D
  • 1M
  • 1Y
15.5100
Interactive TKM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TKM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.9800
Est. EPS (CAD) (12/2014) -0.5620
Est. PEG Ratio -
Market Cap (M CAD) 311.51
Shares Outstanding (M) 21.81
30 Day Average Volume 240,916
Price/Book (mrq) 5.7547
Price/Sale (ttm) 13.2665
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TKM

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for TKM

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.

Mark J MurrayPresident/CEOBruce CousinsExec VP/CFO
Ian MaclachlanExec VP/Chief Technical OfficerMichael J AbramsExec VP/Chief Discovery Officer
More Company Profile & Key Executives for TKM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil